In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

ABSTRACTCarbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-‍fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 European countries between 01 January 2020 and 31 Decemb...

Full description

Bibliographic Details
Main Authors: Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw
Format: Article
Language:English
Published: American Society for Microbiology 2024-04-01
Series:Microbiology Spectrum
Subjects:
cefiderocol
Pseudomonas aeruginosa
Acinetobacter spp.
β‍-‍l‍a‍c‍t‍a‍m‍/‍β‍-‍l‍a‍‍c‍t‍a‍m‍a‍s‍e inhibitor combinations
meropenem
ceftazidime-avibactam
Online Access:https://journals.asm.org/doi/10.1128/spectrum.03836-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.03836-23

Similar Items